Introducing CiPPPA

Circularity in Primary Pharmaceutical Packaging Accelerator

CiPPPA is a collaborative not-for-profit initiative that connects stakeholders across the entire pharmaceutical supply chain to develop and deploy solutions for recycling of primary pharmaceutical packaging.

Our ambition

Reduce waste and recycle pharmaceutical packaging

The initiative seeks to revolutionise the primary pharmaceutical packaging industry by championing sustainable practices, fostering collaboration and commitment, and developing solutions free from competition, for the benefit of all.

Glass_Ribbon_Knot

CiPPPA promotes circularity –
focusing on the renewal of materials,
creating a ripple of change

How CiPPPA works

Learn how our Action Task Forces are working towards solutions

CiPPPA’s Action Task Forces – focusing on blister, inhaler, and injectable packaging – are pivotal in driving the initiative forward. Led by industry experts, their aim is to leverage and optimise existing solutions for pharmaceutical packaging – scaling them for use nationally.

Membership

Join CiPPPA to make an impact in the pharmaceutical industry

CiPPPA aims to reshape the management of pharmaceutical packaging and lead the healthcare industry in environmental stewardship. Join us in this groundbreaking initiative to contribute to industry-wide transformation.

Meet our partners

Latest news & updates

News

CiPPPA Celebrated in Parliamentary Discussion on Sustainable NHS Packaging

In a recent UK parliamentary session, the Circularity in Primary Pharmaceutical Packaging Accelerator (CiPPPA) was highlighted as a key player in the drive towards sustainable healthcare solutions.

Read more
News

New Member Announcement: Sanofi

We are pleased to announce that Sanofi has joined us as a new CiPPPA member.

Read more
News

CiPPPA’s Role in Shaping Sustainable Pharmaceutical Packaging

The latest CPHI Trend Report delves into the complexities and costs associated with sustainable pharmaceutical packaging. CiPPPA Chairman, Duncan Flack, shared his insights on the report.

Read more
Lets talk!